Cancer Research and Treatment

Single-cell RNA-seq reveals MIF−(CD74 + CXCR4) dependent inhibition of macrophages in metastatic papillary thyroid carcinoma

Wei Chen, Xinnian Yu, Huixin Li, Shenglong Yuan, Yuqi Fu, Huanhuan Hu, Fangzhou Liu, Yuan Zhang, Shanliang Zhong

Can Nano Yield Big Insights? Oligonucleotide-Based Biosensors in Early Diagnosis of Gastric Cancer

Alexandra E. Avanu, Alexandra M. Ciubotariu, Gianina Dodi

Late recurrent gastric carcinoma 12 years after surgery with attenuation of CD44 variant 9 expression

Hirokatsu Hayashi, Itaru Yasufuku, Toshiya Higashi, Wakana Chikaishi, Ryoma Yokoi, Masahiro Fukada, Yuta Sato, Ryuichi Asai, Jesse Yu Tajima, Chiemi Saigo, Akitaka Makiyama, Yoshihiro Tanaka, Naoki Okumura, Katsutoshi Murase, Takao Takahashi, Manabu Futam

The Hyaluronan/CD44 Axis: A Double-Edged Sword in Cancer

International Journal of Molecular Sciences.2023; 24(21): 15812. CrossRef

Cyclin D1 Serves as a Poor Prognostic Biomarker in Stage I Gastric Cancer

Se-Il Go, Gyung Hyuck Ko, Won Sup Lee, Jeong-Hee Lee, Sang-Ho Jeong, Young-Joon Lee, Soon Chan Hong, Woo Song Ha

Current Issues in Molecular Biology.2022; 44(3): 1395. CrossRef

Molecular pathogenesis and emerging targets of gastric adenocarcinoma

Journal of Surgical Oncology.2022; 125(7): 1079. CrossRef

Clinical and prognostic significances of cancer stem cell markers in gastric cancer patients: a systematic review and meta-analysis

Mahdieh Razmi, Roya Ghods, Somayeh Vafaei, Maryam Sahlolbei, Leili Saeednejad Zanjani, Zahra Madjd

CD44 polymorphisms and its variants, as an inconsistent marker in cancer investigations

Mohammad Mahmoudi Gomari, Marziye Farsimadan, Neda Rostami, Zahra mahmoudi, Mahmood Fadaie, Ibrahim Farhani, Parastoo Tarighi

Mutation Research/Reviews in Mutation Research.2021; : 108374. CrossRef

Expression of CD44 variant 9 induces chemoresistance of gastric cancer by controlling intracellular reactive oxygen spices accumulation

Tomoko Jogo, Eiji Oki, Ryota Nakanishi, Koji Ando, Yuichiro Nakashima, Yasue Kimura, Hiroshi Saeki, Yoshinao Oda, Yoshihiko Maehara, Masaki Mori

Current therapeutic options for gastric adenocarcinoma

C.R. Akshatha, Smitha Bhat, R. Sindhu, Dharini Shashank, Sarana Rose Sommano, Wanaporn Tapingkae, Ratchadawan Cheewangkoon, Shashanka K. Prasad

Saudi Journal of Biological Sciences.2021; 28(9): 5371. CrossRef

Circulating tumor cell as the functional aspect of liquid biopsy to understand the metastatic cascade in solid cancer

Luis Enrique Cortés-Hernández, Zahra Eslami-S, Catherine Alix-Panabières

Molecular Aspects of Medicine.2020; 72: 100816. CrossRef

Decrease in MiR-148a Expression During Initiation of Chief Cell Transdifferentiation

Takahiro Shimizu, Yoojin Sohn, Eunyoung Choi, Christine P. Petersen, Nripesh Prasad, James R. Goldenring

Cellular and Molecular Gastroenterology and Hepatology.2020; 9(1): 61. CrossRef

Identification of novel biomarkers, MUC5AC, MUC1, KRT7, GAPDH, CD44 for gastric cancer

Trop2 is upregulated in the transition to dysplasia in the metaplastic gastric mucosa

Katherine M Riera, Bogun Jang, Jimin Min, Joseph T Roland, Qing Yang, William T Fesmire, Sophie Camilleri‐Broet, Lorenzo Ferri, Woo H Kim, Eunyoung Choi, James R Goldenring

The Journal of Pathology.2020; 251(3): 336. CrossRef

Prognostic value of CD44v9 expression in human cancers: Retraction

Roles of Proteoglycans and Glycosaminoglycans in Cancer Development and Progression

Jinfen Wei, Meiling Hu, Kaitang Huang, Shudai Lin, Hongli Du

International Journal of Molecular Sciences.2020; 21(17): 5983. CrossRef

The Significance of CD44 Variant 9 in Resected Lung Adenocarcinoma: Correlation with Pathological Early-Stage and EGFR Mutation

Takaki Akamine, Tetsuzo Tagawa, Kayo Ijichi, Gouji Toyokawa, Shinkichi Takamori, Fumihiko Hirai, Tatsuro Okamoto, Yoshinao Oda, Yoshihiko Maehara

Annals of Surgical Oncology.2019; 26(5): 1544. CrossRef

Cancer Stem-Cell Marker CD44v9-Positive Cells Arise From Helicobacter pylori–Infected CAPZA1-Overexpressing Cells

Hitoshi Tsugawa, Chihiro Kato, Hideki Mori, Juntaro Matsuzaki, Kaori Kameyama, Hideyuki Saya, Masanori Hatakeyama, Makoto Suematsu, Hidekazu Suzuki

Cellular and Molecular Gastroenterology and Hepatology.2019; 8(3): 319. CrossRef

hnRNPK promotes gastric tumorigenesis through regulating CD44E alternative splicing

Wei-zhao Peng, Ji-xi Liu, Chao-feng Li, Ren Ma, Jian-zheng Jie

The Use of CD44 Variant 9 and Ki-67 Combination Can Predicts Prognosis Better Than Their Single Use in Early Gastric Cancer

Se-Il Go, Gyung Hyuck Ko, Won Sup Lee, Jeong-Hee Lee, Sang-Ho Jeong, Young-Joon Lee, Soon Chan Hong, Woo Song Ha

Cancer Research and Treatment.2019; 51(4): 1411. CrossRef

Variant isoforms of CD44 involves acquisition of chemoresistance to cisplatin and has potential as a novel indicator for identifying a cisplatin-resistant population in urothelial cancer

Masayuki Hagiwara, Eiji Kikuchi, Nobuyuki Tanaka, Takeo Kosaka, Shuji Mikami, Hideyuki Saya, Mototsugu Oya

Glutamate-cysteine ligase catalytic subunit is associated with cisplatin resistance in lung adenocarcinoma

Noriko Hiyama, Takahiro Ando, Keita Maemura, Toshio Sakatani, Yosuke Amano, Kousuke Watanabe, Hidenori Kage, Yutaka Yatomi, Takahide Nagase, Jun Nakajima, Daiya Takai

Japanese Journal of Clinical Oncology.2018; 48(4): 303. CrossRef

Overexpression of CD44 Variant 9: A Novel Cancer Stem Cell Marker in Human Cholangiocarcinoma in Relation to Inflammation

Nattawan Suwannakul, Ning Ma, Raynoo Thanan, Somchai Pinlaor, Piti Ungarreevittaya, Kaoru Midorikawa, Yusuke Hiraku, Shinji Oikawa, Shosuke Kawanishi, Mariko Murata

Mediators of Inflammation.2018; 2018: 1. CrossRef

Expression of CD44, CD44v9, ABCG2, CD24, Bmi‑1 and ALDH1 in stage I and II oral squamous cell carcinoma and their association with clinicopathological factors

Tetsuya Tamatani, Natsumi Takamaru, Go Ohe, Kazuya Akita, Takayuki Nakagawa, Youji Miyamoto

Ruo-Lin Wu, Lei Huang, Hong-Chuan Zhao, Xiao-Ping Geng

Journal of Cancer Research and Clinical Oncology.2017; 143(1): 1. CrossRef

Prognostic impact of Ki-67 in patients with gastric cancer—the importance of depth of invasion and histologic differentiation

Gyung Hyuck Ko, Se-Il Go, Won Sup Lee, Jeong-Hee Lee, Sang-Ho Jeong, Young-Joon Lee, Soon Chan Hong, Woo Song Ha

Dose-escalation study for the targeting of CD44v+ cancer stem cells by sulfasalazine in patients with advanced gastric cancer (EPOC1205)

Kohei Shitara, Toshihiko Doi, Osamu Nagano, Chiyo K. Imamura, Takeshi Ozeki, Yuya Ishii, Kenji Tsuchihashi, Shunji Takahashi, Takako E. Nakajima, Shuichi Hironaka, Miki Fukutani, Hiromi Hasegawa, Shogo Nomura, Akihiro Sato, Yasuaki Einaga, Takeshi Kuwata,

CD44 variant 9 expression as a predictor for gastric cancer recurrence: immunohistochemical and metabolomic analysis of surgically resected tissues

Yushi YAMAKAWA, Masatoshi KUSUHARA, Masanori TERASHIMA, Yusuke KINUGASA, Takashi SUGINO, Masato ABE, Toru MOCHIZUKI, Keiichi HATAKEYAMA, Kenjiro KAMI, Ken YAMAGUCHI

Initiation and Maintenance of Gastric Cancer: A Focus on CD44 Variant Isoforms and Cancer Stem Cells

Cellular and Molecular Gastroenterology and Hepatology.2017; 4(1): 55. CrossRef

Phase 1 study of sulfasalazine and cisplatin for patients with CD44v-positive gastric cancer refractory to cisplatin (EPOC1407)

Kohei Shitara, Toshihiko Doi, Osamu Nagano, Miki Fukutani, Hiromi Hasegawa, Shogo Nomura, Akihiro Sato, Takeshi Kuwata, Kai Asai, Yasuaki Einaga, Kenji Tsuchihashi, Kentaro Suina, Yusuke Maeda, Hideyuki Saya, Atsushi Ohtsu

Hypoxia regulates CD44 expression via hypoxia-inducible factor-1α in human gastric cancer cells

Gai Liang, Shuang Li, Wei Du, Qinghua Ke, Jun Cai, Jiyuan Yang

Variant isoforms of CD44 expression in upper tract urothelial cancer as a predictive marker for recurrence and mortality

Masayuki Hagiwara, Eiji Kikuchi, Takeo Kosaka, Shuji Mikami, Hideyuki Saya, Mototsugu Oya

Urologic Oncology: Seminars and Original Investigations.2016; 34(8): 337.e19. CrossRef

Cancer stem cells in human digestive tract malignancies

Fatemeh B. Rassouli, Maryam M. Matin, Morvarid Saeinasab